Market news: Poland will promote common defense funds during its presidency of the European Union.Ningbo Founder: The company intends to use its own or self-raised funds to purchase 40% equity of Junpeng Communication from related party Pengxin Chuangzhan in cash. Ningbo Founder announced that the company intends to use its own or self-raised funds to purchase 40% equity of Junpeng Communication from related party Pengxin Chuangzhan in cash.*ST Zhongli: The company's reorganization plan was approved by the court. *ST Zhongli announced that the company's reorganization plan had been approved by the Suzhou Intermediate People's Court and the reorganization procedure was terminated. The content of the reorganization plan is consistent with the previously disclosed draft, aiming at comprehensively solving the historical problems of the company's 1.805 billion yuan capital occupation and illegal guarantee. In the implementation stage of the reorganization plan, the company will be responsible for implementation and the manager will be responsible for supervision. If it is successfully implemented, it will help to optimize the company's asset-liability structure, enhance its sustainable operation and profitability, and have a significant impact on the relevant financial indicators in 2024.
*ST Masters: It is planned to sell some accounts receivable to Shenzhen Pickup Investment for 60 million yuan. *ST Masters announced that the company plans to transfer the accounts receivable with book value of 16,697,800 yuan (original book value of 171 million yuan) to Shenzhen Pickup Investment Partnership (limited partnership) for 60 million yuan. According to the regulations, the transaction constitutes a related party transaction and does not constitute a major asset reorganization, which needs to be submitted to the company's shareholders' meeting for consideration and approval. The accounts receivable to be transferred this time are all due to the daily business of the company, mainly due to the overdue accounts receivable formed by providing engineering services to the debtor.India's new central bank governor: we must be vigilant and flexible to the challenges we face.Wanfang Development: A supplementary agreement on equity transfer of RMB 12.3 million was signed, and Wanfang Development announced that the company held the 66th meeting of the 9th Board of Directors on December 11th, 2024, at which the Proposal on the Progress of Selling a wholly-owned subsidiary and Signing a Supplementary Agreement was reviewed and approved. The Company signed Supplementary Agreement III to the Equity Transfer Agreement with Beijing Tianyuan and Beijing Baiyu, and Beijing Baiyu will pay the remaining equity transfer amount of RMB 12.3 million to the Company before December 31, 2025. As of the disclosure date of the announcement, Beijing Baiyu has paid 77.7 million yuan of equity transfer to the company, and the remaining 12.3 million yuan of equity transfer has not been paid. The company has transferred its 86.3333% equity of Beijing Tianyuan to Beijing Baiyu, so far, the company holds 13.6667% equity of Beijing Tianyuan.
The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Health Yuan: Obtained the commitment letter of stock repurchase loan from financial institutions of no more than 238 million yuan. Health Yuan announcement, the company recently obtained the commitment letter of loan from Industrial Bank, with a loan amount of no more than 238 million yuan, no more than 90% of the upper limit of repurchase amount, and a loan period of no more than 36 months, which is specially used to repurchase shares of listed companies. The total amount of the company's actual loan and the amount of the repurchased funds shall not exceed the upper limit of the amount of this repurchase program. The commitment letter of the financial institution's stock repurchase loan obtained this time does not represent the company's commitment to the repurchase amount. The specific number of shares repurchased shall be subject to the actual number of shares repurchased at the expiration of the repurchase period.Beijing Auto: BAIC Investment and Hyundai Motor invested US$ 1.095 billion in Beijing Hyundai. Beijing Auto announced that on December 11, 2024, BAIC Investment and Hyundai Motor entered into an agreement, and both parties agreed to jointly invest US$ 1.095 billion in Beijing Hyundai according to the proportion of their respective registered capital, and both parties invested US$ 548 million respectively. The capital injection will be carried out in stages. After the capital injection is completed, the registered capital of Beijing Hyundai will increase to US$ 4.074 billion, and Beijing Hyundai will still be owned by BAIC Investment and Hyundai Motor respectively, and will continue to be accounted for as a joint venture of the Company.